Marc Van Dijk
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marc Van Dijk
The proxy statement of MiNK Therapeutics, Inc. reports total compensation of $402,479 for Marc Van Dijk in fiscal 2024, including a base salary of $341,796. Disclosed compensation is on record for 4 fiscal years. Marc Van Dijk has spoken on 1 earnings call across 1 company, most recently for MiNK Therapeutics, Inc. on August 13, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
MiNK Therapeutics, Inc. (INKT)
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at MiNK Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Melissa Orilall CFO
- Austin Charette Chief Accounting Officer
- Dr. John Holcomb Board Member
- Jennifer Buell Board Member
- John Holcomb Board Member
- Peter Behner Board Member
- Robert Kadlec Board Member
- Ulf Wiinberg Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | MiNK Therapeutics, Inc. (INKT) | Strategic Consultant and Scientific Advisory Board Member; Former Chief Scientific Officer | $341,796 | $402,479 |
| 2023 | MiNK Therapeutics, Inc. (INKT) | Strategic Consultant and Scientific Advisory Board Member; Former Chief Scientific Officer | $333,989 | $568,829 |
| 2022 | MiNK Therapeutics, Inc. (INKT) | Chief Scientific Officer | $252,334 | $651,174 |
| 2021 | MiNK Therapeutics, Inc. (INKT) | Chief Scientific Officer | — | $107,074 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.